HGS Responsibilities Sample Clauses

The "HGS Responsibilities" clause defines the specific duties and obligations that HGS, as a party to the agreement, is required to fulfill. This may include providing certain services, meeting performance standards, maintaining compliance with applicable laws, or delivering reports and updates as stipulated in the contract. By clearly outlining what is expected from HGS, this clause ensures accountability and helps prevent misunderstandings or disputes regarding the scope of HGS's role in the contractual relationship.
HGS Responsibilities. HGS shall have the sole right and responsibility to record all payments for sales of Collaboration Products throughout the United States and GSK shall have the sole right and responsibility to [***]. HGS shall use Diligent Efforts to employ an appropriate management infrastructure to supervise the Sales Representatives required to oversee HGS obligations to perform Detail Requirements and marketing staff of sufficient size to establish, maintain and implement the Marketing Plan for the Collaboration Products; and HGS shall also be responsible for all medical inquiries in the Territory as set forth in Section 8.2.4 and Regional medical scientists relating to Collaboration Product, unless otherwise agreed upon by the Parties.
HGS Responsibilities. (a) Albumin Fusion Patent Rights, Albuferon Patent Rights and HGS Arising Patent Rights. HGS, or the Party who bears such responsibility under the AB License, will prepare, file, prosecute and maintain all Albumin Fusion Patent Rights, Albuferon Patent Rights and HGS Arising Patent Rights. HGS shall, in a timely fashion, provide NVS with copies of all written correspondence with the United States Patent and Trademark Office and all substantive communications from foreign patent offices pertaining to the filing, prosecution and maintenance of the Albumin Fusion Patent Rights (to the extent related to Collaboration Product), the Albuferon Patent Rights and the HGS Arising Patent Rights, and shall provide NVS with a timely and adequate opportunity to review and provide written comments on such matters which shall be reasonably taken into account by HGS or the outside counsel prosecuting such patent rights. HGS shall keep NVS advised on a quarterly basis, through the JEC, on the status of pending patent applications, including the grant of any Albumin Fusion Patent Rights (to the extent related to Collaboration Product), Albuferon Patent Rights and HGS Arising Patent Rights. NVS may identify in writing to HGS certain countries in which NVS desires that HGS, or the party who bears such responsibility under the AB License, file, prosecute and maintain certain Albumin Fusion Patent Rights (to the extent related to Collaboration Product), Albuferon Patent Rights and/or HGS Arising Patent Rights. In the case of the Albumin Fusion Patent Rights (to the extent related to Collaboration Product), Albuferon Patent Rights and/or HGS Arising Patent Rights, including those HGS Arising Patent Rights for which HGS bears responsibility under the AB License, HGS shall thereafter file, prosecute and maintain such Albumin Fusion Patent Rights (to the extent related to Collaboration Product), Albuferon Patent Rights and/or HGS Arising Patent Rights in such country or countries. If HGS decides not to file, prosecute or maintain the Albumin Fusion Patent Rights (to the extent related to Collaboration Product), Albuferon Patent Rights or the HGS Arising Patent Rights in such countries identified by NVS and provided that HGS has the right to grant such right to NVS, HGS shall notify NVS of such decision in a timely fashion, and upon NVS request, HGS, in collaboration with NVS and using outside counsel mutually acceptable to HGS and NVS, shall file, prosecute and maintain such Albumin...
HGS Responsibilities. (a) HGS shall have the sole right and responsibility to record and collect payment for sales of Collaboration Products throughout the United States; and (b) HGS shall use Commercially Reasonable Efforts to employ an appropriate management infrastructure to supervise the Sales Representatives required to oversee HGS’ obligations to perform Detail Requirements and marketing staff of sufficient size to establish, maintain and implement the Marketing Plan for the Collaboration Products.
HGS Responsibilities. HGS shall fulfill and discharge all obligations under applicable Law, as well as procedures ensuring timely compliance with all Laws as are reasonable in accordance with accepted business practices and legal requirements to maintain the authorization and/or ability to Manufacture Collaboration Product in the Territory, and to Commercialize Collaboration Product in the Territory, including, without limitation, the following: 8.2.1 The maintenance of all Regulatory Approvals necessary for the Manufacture of Collaboration Product in the Territory in accordance with cGMP, and for the use and Commercialization of Collaboration Product for all approved indications in the United States, including, without limitation, maintaining such records and filing such reports as may be required under the provisions of the U.S. Federal Food, Drug and Cosmetic Act, as well as all other Laws, including, without limitation, all advertising and promotional literature and labeling in the United States relating to Collaboration Product. 8.2.2 Timely filing with appropriate Regulatory Authorities of all Adverse Event reports related to Collaboration Product in the United States. The procedures for sharing and reporting of Adverse Events encountered by each Party for Collaboration Product in the Territory shall be as set forth in a Safety Data Exchange Agreement, which shall be entered into by the Parties in accordance with the terms of Section 8.4 below. 8.2.3 Creation of a master safety database which shall cross-reference any Adverse Events relating to Collaboration Product in the United States, in accordance with the Safety Data Exchange Agreement to be entered into by the Parties pursuant to Section 8.4.2 below.